Pfizer Inc. v. Teva Pharmaceuticals Usa, Inc.
Pfizer Inc. v. Teva Pharmaceuticals Usa, Inc.
Opinion
Case: 12-1576 Document: 79 Page: 1 Filed: 11/09/2012
NOTE: This order is nonprecedential.
mtniteb ~tate~ Qrourt of §ppeaI~ for tbe jfeberaI Qrirtuit
PFIZER INC., WARNER-LAMBERT COMPANY LLC, AND C.P. PHARMACEUTICALS INTERNATIONAL C.V., Plaintiffs-Appellees,
AND NORTHWESTERN UNIVERSITY, Plaintiff-Appellee,
v. TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellants,
AND LUPIN, LTD. AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants,
AND
ACTAVIS, INC. AND ACTAVIS ELIZABETH, LLC, Defendants-Appellants,
AND COBALT LABORATORIES, INC. AND COBALT PHARMACEUTICALS, INC., Defendants-Appellants, Case: 12-1576 Document: 79 Page: 2 Filed: 11/09/2012
PFIZER INC. V. TEVA PHARMACEUTICALS USA 2
AND
SUN PHARMA GLOBAL, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., AND SUN PHARMACEUTICAL INDUSTRIES, INC., Defendants-Appellants,
AND
WOCKHARDT LIMITED AND WOCKHARDT USA, LLC, Defendants-Appellants,
AND
ALPHAPHARM PTY. LTD. AND MYLAN PHARMACEUTICALS, INC., Defendants-Appellants.
2012-1576, -1601, -1602, -1603, -1604, -1605, -1607
Appeals from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0307, Chief Judge Gregory M. Sleet.
ON MOTION
ORDER Sun Pharma Global, Inc., Sun Pharmaceutical Indus- tries, Ltd., and Sun Pharmaceutical Industries, Inc. move to withdraw Robert Breisblatt and Jeremy Daniel as Case: 12-1576 Document: 79 Page: 3 Filed: 11/09/2012
PFIZER INC. V. TEVA PHARMACEUTICALS USA 3
counsel and substitute Barry P. Golob as principal coun- sel.
Upon consideration thereof,
IT Is ORDERED THAT: The motion is granted.
FOR THE COURT
/s/ Jan Horbaly Jan Horbaly Clerk s26
Reference
- Status
- Unpublished